Anzemet and Radiation oesophagitis - a phase IV clinical study of FDA data
No or few reports are found.
The phase IV clinical study is created by eHealthMe based on reports from the FDA, and is updated regularly.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 700+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
No or few reports are found.
What is Anzemet?
Anzemet has active ingredients of dolasetron mesylate. Currently, eHealthMe is studying from 2,603 Anzemet users.
What is Radiation Oesophagitis?
Radiation oesophagitis (inflammation of oesophagus due to radiation) is found to be associated with 437 drugs and 257 conditions by eHealthMe. Currently, we are studying 538 people who have Radiation oesophagitis.
Do you take Anzemet and have Radiation oesophagitis?Check whether Radiation oesophagitis is associated with a drug or a condition
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Anzemet side effects by duration, gender and age:
- Anzemet side effects (2,603 reports)
Radiation oesophagitis treatments and more:
- Radiation oesophagitis (538 reports)
All the drugs that are associated with Radiation oesophagitis:
All the conditions that are associated with Radiation oesophagitis:
How the study uses the data?
The study uses data from the FDA. It is based on dolasetron mesylate (the active ingredients of Anzemet) and Anzemet (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 700+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Glycopyrrolate and Pain In Extremity - 4 seconds ago
- Truvada and Depakote Er drug interaction - 8 seconds ago
- Phenergan and Piroxicam drug interaction - 12 seconds ago
- Memantine Hydrochloride and Dyskinesia Aggravated - 18 seconds ago
- Caspofungin Acetate and Benzonatate drug interaction - 19 seconds ago
- Crestor and Afrezza drug interaction - 22 seconds ago
- Serzone and Triazolam drug interaction - 27 seconds ago
- Doxazosin Mesylate and Qvar 40 drug interaction - 28 seconds ago
- Retevmo and Diarrhea - 31 seconds ago
- Retevmo and Stools - Watery - 31 seconds ago